Company / FCF Margin
Vistagen Therapeutics, Inc. FCF Margin History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-4080.8%
FY2023
5-year range
-4080.8% / -600.1%
FY2019-FY2023
Trend
-17.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -600.1% to -4080.8% over the past 5 years.
Based on SEC 10-K filings.
-4080.8% in FY2023.
Declined from -600.1% to -4080.8% over the past 5 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -3480.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, fcf margin decreased 17.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -4080.8% | -17.0% |
| FY2022 | -3488.4% | - |
| FY2021 | - | - |
| FY2018 | -600.1% | - |
| FY2017 | - | - |
| FY2014 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026